Protalix Biotherapeutics Inc., a pharmaceutical company, said Tuesday its chairman of the board is resigning to recover from an illness.
Drug and medical products company Abbott Laboratories said Tuesday it will buy Facet Biotech Corp. for about $450 million in cash, expanding the company's access to biotechnology drugs, including a potential treatment for multiple sclerosis.